Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres F Lasave

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The British Journal of Ophthalmology|August 18, 2017
Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study GroupJay Chhablani, Remya Mareen Paulose, Andres F Lasave, et al.
Ocular Immunology and Inflammation|October 1, 2019
Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for Birdshot RetinochoroidopathyCaiyun You, Andres F Lasave, Buraa Kubaisi, et al.
Retina (Philadelphia, Pa.)|November 4, 2015
INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: 5-Year Results of The Pan-American Collaborative Retina Study GroupJ Fernando Arevalo, Andres F Lasave, Lihteh Wu, et al.
The British Journal of Ophthalmology|February 26, 2016
Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study groupJ Fernando Arevalo, Andres F Lasave, Lihteh Wu, et al.
Ocular Immunology and Inflammation|October 11, 2018
Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study GroupJ Fernando Arevalo, Andres F Lasave, Vishali Gupta, et al.
Journal of Ophthalmology|May 18, 2011
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF LectureJ Fernando Arevalo, Juan G Sanchez, Andres F Lasave, et al.
Current Diabetes Reviews|July 3, 2010
Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas LectureJ Fernando Arevalo, Juan G Sanchez, Andres F Lasave, et al.
Journal of Vitreoretinal Diseases|June 1, 2026
Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation-Treated Eyes With Proliferative Diabetic RetinopathyJ Fernando Arevalo, Andres F Lasave, Lihteh Wu, et al.
American Journal of Ophthalmology|May 17, 2019
Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical TrialJ Fernando Arevalo, Andres F Lasave, Igor Kozak, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 6, 2023
Early-Phase Perceptions of COVID-19's Impact on Ophthalmology Practice Patterns: A Survey from the Pan-American Association of OphthalmologyFrancisco Javier Bonilla-Escobar, Daniel Sánchez-Cano, Andres F Lasave, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The British Journal of Ophthalmology|August 18, 2017
Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study GroupJay Chhablani, Remya Mareen Paulose, Andres F Lasave, et al.
Ocular Immunology and Inflammation|October 1, 2019
Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for Birdshot RetinochoroidopathyCaiyun You, Andres F Lasave, Buraa Kubaisi, et al.
Retina (Philadelphia, Pa.)|November 4, 2015
INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: 5-Year Results of The Pan-American Collaborative Retina Study GroupJ Fernando Arevalo, Andres F Lasave, Lihteh Wu, et al.
The British Journal of Ophthalmology|February 26, 2016
Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study groupJ Fernando Arevalo, Andres F Lasave, Lihteh Wu, et al.
Ocular Immunology and Inflammation|October 11, 2018
Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study GroupJ Fernando Arevalo, Andres F Lasave, Vishali Gupta, et al.
Journal of Ophthalmology|May 18, 2011
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF LectureJ Fernando Arevalo, Juan G Sanchez, Andres F Lasave, et al.
Current Diabetes Reviews|July 3, 2010
Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas LectureJ Fernando Arevalo, Juan G Sanchez, Andres F Lasave, et al.
Journal of Vitreoretinal Diseases|June 1, 2026
Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation-Treated Eyes With Proliferative Diabetic RetinopathyJ Fernando Arevalo, Andres F Lasave, Lihteh Wu, et al.
American Journal of Ophthalmology|May 17, 2019
Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical TrialJ Fernando Arevalo, Andres F Lasave, Igor Kozak, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 6, 2023
Early-Phase Perceptions of COVID-19's Impact on Ophthalmology Practice Patterns: A Survey from the Pan-American Association of OphthalmologyFrancisco Javier Bonilla-Escobar, Daniel Sánchez-Cano, Andres F Lasave, et al.
Pageof 3